|
⚲
|
| Keyboard |
| Dolan Matthew Vincent
✚
|
|
|---|---|
| CIK # | 0001914994 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001914994] | |
| 4 | [0001914994] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dolan Matthew Vincent | |
| Dexcom Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dexcom Inc DXCM
Common Stock
|
2025-01-29 | Sell | 1,183 | $86.91 | 102,815 |
|
Dexcom Inc DXCM
Common Stock
|
2025-01-28 | Grant | 3,048 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2024-05-15 | Sell | 2,423 | $126.58 | 306,703 |
|
Dexcom Inc DXCM
Common Stock
|
2024-04-15 | Sell | 1,990 | $137.81 | 274,242 |
|
Dexcom Inc DXCM
Common Stock
|
2024-03-15 | Sell | 1,886 | $129.18 | 243,633 |
|
Dexcom Inc DXCM
Common Stock
|
2024-03-15 | Sell | 1,003 | $131.39 | 131,784 |
|
Dexcom Inc DXCM
Common Stock
|
2024-03-15 | Sell | 1,314 | $130.77 | 171,832 |
|
Dexcom Inc DXCM
Common Stock
|
2024-03-12 | Sell | 6,710 | $134.41 | 901,891 |
|
Dexcom Inc DXCM
Common Stock
|
2024-03-08 | Grant | 21,711 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2023-09-01 | Sell | 56 | $102.32 | 5,730 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-16 | Sell | 2,303 | $115.00 | 264,845 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-13 | Sell | 6,229 | $106.27 | 661,956 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-10 | Disposed to issuer | 2,397 | $111.40 | 267,026 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-10 | Disposed to issuer | 787 | $111.40 | 87,672 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-10 | Disposed to issuer | 1,650 | $111.40 | 183,810 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-10 | Disposed to issuer | 1,370 | $111.40 | 152,618 |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-08 | Grant | 21,769 | $0.00 | |
|
Dexcom Inc DXCM
Common Stock
|
2023-03-06 | Sell | 226 | $114.40 | 25,854 |
|
Dexcom Inc DXCM
Common Stock
|
2022-09-01 | Sell | 5 | $81.63 | 408 |
|
Dexcom Inc DXCM
Common Stock
|
2022-03-17 | Sell | 484 | $450.00 | 217,800 |
| showing 20 of 27 most recent transactions | |||||